ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,732 | -31.8% | 16,204 | -0.5% | 0.00% | – |
| Q2 2023 | $48,020 | -82.6% | 16,278 | -85.3% | 0.00% | – |
| Q1 2023 | $275,913 | -22.3% | 110,365 | -1.5% | 0.00% | – |
| Q4 2022 | $355,262 | +9.0% | 112,070 | +2.1% | 0.00% | – |
| Q3 2022 | $326,000 | +13.6% | 109,796 | +16.4% | 0.00% | – |
| Q2 2022 | $287,000 | -79.7% | 94,300 | -10.0% | 0.00% | – |
| Q1 2022 | $1,415,000 | +4.6% | 104,818 | +0.9% | 0.00% | – |
| Q4 2021 | $1,353,000 | +48.0% | 103,858 | +6.6% | 0.00% | – |
| Q3 2021 | $914,000 | +7.2% | 97,401 | +17.0% | 0.00% | – |
| Q2 2021 | $853,000 | +30.0% | 83,270 | +133.4% | 0.00% | – |
| Q1 2021 | $656,000 | -52.1% | 35,678 | -10.7% | 0.00% | – |
| Q4 2020 | $1,369,000 | – | 39,971 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |